Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ranibizumab (lucentis) (1 trial)
Depression (Phase 1)
Retinal Vein Occlusion (Phase 1)
Trials (1 total)
Trial APIs (1 total)